Related Experiment Video
Updated: Mar 8, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Beyond CHA 2 DS 2 -VASc: Hemodynamic and Morphologic Discriminants for Thrombus Formation and Stroke in Atrial
Henrik Aasen Kjeldsberg1, Josquin Harrison2, Maxime Sermesant2
1Department of Computational Physiology, Simula Research Laboratory, Oslo, Norway.
Purpose:
Stroke is a leading cause of death worldwide, with atrial fibrillation (AF) contributing to up to a third of ischemic strokes. Current clinical risk scores, like the CHA DS -VASc score, have limited accuracy and do not account for the underlying mechanisms of thrombus formation and stroke. This study investigates the potential of supplementing the CHA DS -VASc score with information about the form and function of the left atrium (LA) using computational fluid dynamics (CFD)-based flow parameters and morphometrics.
Methods:
We analyzed 40 patient-specific LA models reconstructed from computed tomography, incorporating a physiologically realistic atrial wall motion derived from an AF motion model. High-fidelity CFD simulations were performed under pathological conditions to compute hemodynamic and morphometric parameters, which were then statistically correlated with thrombus presence or stroke history.
Results:
Univariate logistic analysis showed that LA volume, left atrial appendage (LAA) orifice size, and LAA depth correlated strongly with thrombus presence or stroke history (Pseudo = 0.57, 0.55, 0.47, respectively). Additionally, increased LA blood residence time (BRT) showed a strong correlation with thrombus or stroke (Pseudo = 0.61). When combined with CHA DS -VASc multivariate logistic regression produced strong Pseudo scores of 0.75, 0.75, and 0.76 for LAA orifice size, LAA depth, and LA BRT, respectively.
Conclusion:
These results demonstrate that CFD-based and morphometric parameters can complement the CHA DS -VASc score, potentially improving the assessment of thrombus formation and stroke risk in AF patients, which could support more personalized treatment options.

